On pooled analysis, we found that individuals with at least one copy of the CYP2C19*2 A allele had a 3.19-fold increased risk (adjusted 95% CI: 2.21–4.61, P < 0.001) of ESCC compared with those without this allele. The gene discussed is CYP2C19; the disease is esophageal squamous cell carcinoma.